Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
ATAI Life Sciences AG See All Filings	D	2020-12-07 15:55:43 UTC
Amount To Be Raised $93,616,029 Associated Brokers / Dealers N/A CIK Number 0001776242 Filed Document 0001776242-20-000004 Exclusions or Exemptions 506b Accepted Date 2020-12-07 15:55:43 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business GERMANY Revenue or Assets Decline to Disclose Type of Security Debt
ATAI Life Sciences AG See All Filings	D/A	2020-10-20 13:25:56 UTC
Amount To Be Raised $33,440,400 Associated Brokers / Dealers N/A CIK Number 0001776242 Filed Document 0001776242-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-10-20 13:25:56 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business GERMANY Revenue or Assets Decline to Disclose Type of Security Debt
ATAI Life Sciences AG See All Filings	D	2020-01-22 20:33:36 UTC
Amount To Be Raised $33,440,400 Associated Brokers / Dealers N/A CIK Number 0001776242 Filed Document 0001776242-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-22 20:33:36 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business GERMANY Revenue or Assets Decline to Disclose Type of Security Debt
ATAI Life Sciences AG See All Filings	D	2019-05-17 17:22:33 UTC
Amount To Be Raised $42,752,200 Associated Brokers / Dealers N/A CIK Number 0001776242 Filed Document 0001776242-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-05-17 17:22:33 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business GERMANY Revenue or Assets Decline to Disclose Type of Security Equity
ATAI Life Sciences AG See All Filings	D	2019-05-17 16:40:12 UTC
Amount To Be Raised $23,441,970 Associated Brokers / Dealers N/A CIK Number 0001776242 Filed Document 0001776242-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-05-17 16:40:12 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business GERMANY Revenue or Assets Decline to Disclose Type of Security Equity